Barriers and Solutions to a Recently Noted Failure of Diabetes Care Outcomes to Improve From 2005 to 2016 in the United States
- PMID: 31595785
- PMCID: PMC7189157
- DOI: 10.1177/1932296819880861
Barriers and Solutions to a Recently Noted Failure of Diabetes Care Outcomes to Improve From 2005 to 2016 in the United States
Conflict of interest statement
Comment on
-
Evaluation of the Cascade of Diabetes Care in the United States, 2005-2016.JAMA Intern Med. 2019 Oct 1;179(10):1376-1385. doi: 10.1001/jamainternmed.2019.2396. JAMA Intern Med. 2019. PMID: 31403657 Free PMC article.
References
-
- Hernandez I, Good C, Cutler DM, Gellad WF, Parekh N, Shrank WH. The contribution of new product entry versus product inflation on the rising costs of drugs. Health Aff (Millwood). 2019;38(1):76-83. - PubMed
-
- Hoppe C, Kerr D. Minority underrepresentation in cardiovascular outcome trials for type 2 diabetes. Lancet Diabetes Endocrinol. 2017;5(1):13. - PubMed
-
- Sinclair AJ, Paolisso G, Castro M, Bourdel-Marchasson I, Gadsby R, Rodriguez Mañas L; European Diabetes Working Party for Older People. European Diabetes Working Party for Older People 2011 clinical guidelines for type 2 diabetes mellitus. Executive summary. Diabetes Metab. 2011;37(suppl 3):S27–S38. - PubMed
-
- Tasci I, Safer U, Naharci I, Sonmez A. Mismatch between ADA and AGS recommendations for glycated hemoglobin targets for older adults. Prim Care Diabetes. 2018;12(2):192-194. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical